132 related articles for article (PubMed ID: 12634969)
1. 11C-metomidate PET imaging of adrenocortical cancer.
Khan TS; Sundin A; Juhlin C; Långström B; Bergström M; Eriksson B
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):403-10. PubMed ID: 12634969
[TBL] [Abstract][Full Text] [Related]
2. PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate.
Bergström M; Juhlin C; Bonasera TA; Sundin A; Rastad J; Akerström G; Långström B
J Nucl Med; 2000 Feb; 41(2):275-82. PubMed ID: 10688111
[TBL] [Abstract][Full Text] [Related]
3. Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.
Minn H; Salonen A; Friberg J; Roivainen A; Viljanen T; Långsjö J; Salmi J; Välimäki M; Någren K; Nuutila P
J Nucl Med; 2004 Jun; 45(6):972-9. PubMed ID: 15181132
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors.
Bergström M; Bonasera TA; Lu L; Bergström E; Backlin C; Juhlin C; Långström B
J Nucl Med; 1998 Jun; 39(6):982-9. PubMed ID: 9627330
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.
Zettinig G; Mitterhauser M; Wadsak W; Becherer A; Pirich C; Vierhapper H; Niederle B; Dudczak R; Kletter K
Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1224-30. PubMed ID: 15197504
[TBL] [Abstract][Full Text] [Related]
6. [11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings.
Hennings J; Lindhe O; Bergström M; Långström B; Sundin A; Hellman P
J Clin Endocrinol Metab; 2006 Apr; 91(4):1410-4. PubMed ID: 16403816
[TBL] [Abstract][Full Text] [Related]
7. PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate.
Gross MD; Shapiro B; Kloos RT; Dwamena B
J Nucl Med; 2000 Nov; 41(11):1933-4. PubMed ID: 11079507
[No Abstract] [Full Text] [Related]
8. [¹²³I]Iodometomidate imaging in adrenocortical carcinoma.
Kreissl MC; Schirbel A; Fassnacht M; Haenscheid H; Verburg FA; Bock S; Saeger W; Knoedler P; Reiners C; Buck AK; Allolio B; Hahner S
J Clin Endocrinol Metab; 2013 Jul; 98(7):2755-64. PubMed ID: 23609836
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas.
Burton TJ; Mackenzie IS; Balan K; Koo B; Bird N; Soloviev DV; Azizan EA; Aigbirhio F; Gurnell M; Brown MJ
J Clin Endocrinol Metab; 2012 Jan; 97(1):100-9. PubMed ID: 22112805
[TBL] [Abstract][Full Text] [Related]
10. Para-chloro-2-[
Silins I; Sundin A; Nordeman P; Jahan M; Estrada S; Monazzam A; Lubberink M; Aigbirhio F; Hellman P; Antoni G
Int J Med Sci; 2021; 18(10):2187-2196. PubMed ID: 33859526
[No Abstract] [Full Text] [Related]
11. [Differential diagnosis in adrenal gland tumors using PET and 11C-metomidate].
Juhlin C; Törnblom S; Rastad J; Bergström M; Bonasera T; Sundin A; Långström B
Nord Med; 1998 Nov; 113(9):306-7. PubMed ID: 9835764
[TBL] [Abstract][Full Text] [Related]
12. The role of PET in localization of neuroendocrine and adrenocortical tumors.
Eriksson B; Bergström M; Sundin A; Juhlin C; Orlefors H; Oberg K; Långström B
Ann N Y Acad Sci; 2002 Sep; 970():159-69. PubMed ID: 12381551
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.
Hennings J; Hellman P; Ahlström H; Sundin A
Eur J Radiol; 2009 Feb; 69(2):314-23. PubMed ID: 18082990
[TBL] [Abstract][Full Text] [Related]
14. Masked volume wise Principal Component Analysis of small adrenocortical tumours in dynamic [11C]-metomidate Positron Emission Tomography.
Razifar P; Hennings J; Monazzam A; Hellman P; Långström B; Sundin A
BMC Med Imaging; 2009 Apr; 9():6. PubMed ID: 19386097
[TBL] [Abstract][Full Text] [Related]
15. Metomidate-based imaging of adrenal masses.
Hahner S; Sundin A
Horm Cancer; 2011 Dec; 2(6):348-53. PubMed ID: 22124841
[TBL] [Abstract][Full Text] [Related]
16. Uptake of [N-methyl-11C]alpha-methylaminoisobutyric acid in untreated head and neck cancer studied by PET.
Sutinen E; Jyrkkiö S; Alanen K; Någren K; Minn H
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):72-7. PubMed ID: 12483412
[TBL] [Abstract][Full Text] [Related]
17. Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancy.
Leboulleux S; Deandreis D; Escourrou C; Al Ghuzlan A; Bidault F; Aupérin A; Travagli JP; Lumbroso J; Schlumberger M; Baudin E
Eur J Endocrinol; 2011 Jan; 164(1):89-94. PubMed ID: 20921280
[TBL] [Abstract][Full Text] [Related]
18. [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes.
Hahner S; Stuermer A; Kreissl M; Reiners C; Fassnacht M; Haenscheid H; Beuschlein F; Zink M; Lang K; Allolio B; Schirbel A
J Clin Endocrinol Metab; 2008 Jun; 93(6):2358-65. PubMed ID: 18397978
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
Yun M; Kim W; Alnafisi N; Lacorte L; Jang S; Alavi A
J Nucl Med; 2001 Dec; 42(12):1795-9. PubMed ID: 11752075
[TBL] [Abstract][Full Text] [Related]
20. Visualisation of bladder cancer using (11)C-choline PET: first clinical experience.
de Jong IJ; Pruim J; Elsinga PH; Jongen MM; Mensink HJ; Vaalburg W
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1283-8. PubMed ID: 12271408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
